Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.31
-0.59 (-3.96%)
Sep 11, 2026, 4:08 PM HKT

HKG:2659 Statistics

Total Valuation

HKG:2659 has a market cap or net worth of HKD 4.86 billion. The enterprise value is 4.14 billion.

Market Cap4.86B
Enterprise Value 4.14B

Important Dates

The last earnings date was Friday, August 28, 2026.

Earnings Date Aug 28, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2659 has 325.89 million shares outstanding. The number of shares has increased by 9.81% in one year.

Current Share Class 154.23M
Shares Outstanding 325.89M
Shares Change (YoY) +9.81%
Shares Change (QoQ) +11.47%
Owned by Insiders (%) 30.33%
Owned by Institutions (%) 6.19%
Float 98.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 246.82
PB Ratio 2.90
P/TBV Ratio 2.93
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 210.37
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.29.

Current Ratio 3.85
Quick Ratio 3.34
Debt / Equity 0.29
Debt / EBITDA n/a
Debt / FCF -0.90
Interest Coverage -46.54

Financial Efficiency

Return on equity (ROE) is -31.30% and return on invested capital (ROIC) is -12.37%.

Return on Equity (ROE) -31.30%
Return on Assets (ROA) -10.46%
Return on Invested Capital (ROIC) -12.37%
Return on Capital Employed (ROCE) -16.04%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 54,048
Profits Per Employee -1.16M
Employee Count 364
Asset Turnover 0.01
Inventory Turnover 0.51

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 17.31
200-Day Moving Average n/a
Relative Strength Index (RSI) 27.04
Average Volume (20 Days) 399,656

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2659 had revenue of HKD 19.67 million and -422.41 million in losses. Loss per share was -1.37.

Revenue19.67M
Gross Profit 13.12M
Operating Income -343.63M
Pretax Income -422.41M
Net Income -422.41M
EBITDA -300.88M
EBIT -343.63M
Loss Per Share -1.37
Full Income Statement

Balance Sheet

The company has 1.21 billion in cash and 488.53 million in debt, with a net cash position of 716.99 million or 2.20 per share.

Cash & Cash Equivalents 1.21B
Total Debt 488.53M
Net Cash 716.99M
Net Cash Per Share 2.20
Equity (Book Value) 1.67B
Book Value Per Share 5.13
Working Capital 1.04B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -255.69 million and capital expenditures -289.45 million, giving a free cash flow of -545.14 million.

Operating Cash Flow -255.69M
Capital Expenditures -289.45M
Depreciation & Amortization 43.29M
Net Borrowing 206.13M
Free Cash Flow -545.14M
FCF Per Share -1.67
Full Cash Flow Statement

Margins

Gross Margin 66.69%
Operating Margin -1,746.68%
Pretax Margin -2,147.12%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:2659 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.81%
Shareholder Yield -9.81%
Earnings Yield -8.70%
FCF Yield -11.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2